More News

28 Nov 2018 Genentech Acquires Jecure Therapeutics
28 Nov 2018 Daiichi Sankyo and Roche to Collaborate on New HER2 Low Companion Diagnostic Test
27 Nov 2018 Tactiva Therapeutics Announces License to Oncolytic Vaccinia Virus Armed With CXCR4 Antagonist for Treatment of Ovarian Cancer
27 Nov 2018 Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company
26 Nov 2018 REGENXBIO and Rocket Pharmaceuticals Announce New License Agreement for the Treatment of Danon Disease Using NAV AAV9 Vector
23 Nov 2018 Astellas Executes License Agreement with an Option to Acquire JVS-100 Gene Therapy Program from Juventas
21 Nov 2018 LEO Pharma and PellePharm Announce $760 Million Collaboration to Advance Innovative Therapies for Rare Skin Diseases
20 Nov 2018 Roivant Sciences and iNtRON Bio Sign Licensing Deal for Novel Anti-Superbugs Biologic SAL200
20 Nov 2018 GeoVax and Leidos Enter into a Collaboration Agreement on Immunotherapy Research Program
20 Nov 2018 GEn1E Lifesciences Adds to Development Pipeline with Exclusive Option to License University of Maryland, Baltimore’s MUC1-Ecto-Domain Anti-Bacterial Agent
20 Nov 2018 Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid Tumors
19 Nov 2018 Alvotech and Fuji Pharma Enter into Exclusive Partnership for Development and Commercialization of Biosimilars in Japan
16 Nov 2018 MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210
15 Nov 2018 Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies
15 Nov 2018 Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag
15 Nov 2018 Mission Therapeutics and AbbVie Sign DUBs Collaboration in Alzheimer’s and Parkinson’s Disease
14 Nov 2018 Dragonfly Therapeutics Announces Expansion of its Strategic Collaboration with Celgene, Doubling the Number of Programs and Including Targets for Solid Tumor Indications
13 Nov 2018 DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer
13 Nov 2018 MaxCyte Announces Research Agreement with Kite, a Gilead Company
13 Nov 2018 Medigene AG: Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor
13 Nov 2018 Sobi™ to acquire Synagis® US rights from AstraZeneca - creates a platform for global growth
11 Nov 2018 BioTime and Asterias Biotherapeutics Enter Into Definitive Merger Agreement to Create Leading Cell Therapy Company
09 Nov 2018 CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology
08 Nov 2018 Brooklyn ImmunoTherapeutics Acquires IRX Therapeutics
08 Nov 2018 Saniona signs option agreement with Initiator Pharma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up